3280, 1720, 1660; δH (CDCl3) 2.23 (3H, s), 3.20 (1H, dd, J 18.4,
9.3), 3.60 (1H, dd, J 18.6, 13.8), 3.78 (3H, s), 4.30 (1H, dd,
J 15.2, 6.7), 4.36 (1H, dd, J 15.2, 6.7), 4.70 (1H, dd, J 13.8, 9.3),
6.20 (1H, br t, J 6.7), 6.95–7.10 (9H, m); δC (CDCl3) 20.1 (q),
27.7 (t), 38.6 (t), 53.3 (q), 59.0 (d), 116.7 (d), 128.0–131.3, 132.3
(s), 136.6 (s), 140.0 (s), 162.2 (s), 166.3 (s), 167.9 (s); m/z (EI)
351 (Mϩ).
was washed with water (2 × 50 cm3), dried over Na2SO4 and
evaporated under reduced pressure. The residue was chromato-
graphed on a silica gel column with AcOEt–hexane–CH2Cl2
3 : 6 : 1. The major isomer (5S )-1-(4-methylphenyl)-3-methoxy-
carbonyl-5-{N-[(S )-1-phenylethyl]amino}carbonyl-4,5-dihydro-
pyrazole 13 was eluted first, followed by the minor isomer (5R)-
1-(4-methylphenyl)-3-methoxycarbonyl-5-{N-[(S )-1-phenyl-
ethyl]amino}carbonyl-4,5-dihydropyrazole 14.
13 (0.19 g, 50%) was a white solid. Mp 89 ЊC from i-Pr2O
(Found: C, 69.07; H, 6.30; N, 11.56; C21H23N3O3 requires C,
69.02; H, 6.34; N, 11.50%); [α]2D5 ϩ123.0 (CHCl3, c = 0.22); νmax
(Nujol)/cmϪ1 3180, 1730, 1665; δH (CDCl3) 1.26 (3H, d, J 7.2),
2.25 (3H, s), 3.16 (1H, dd, J 18.0, 13.1), 3.58 (1H, dd, J 18.0,
6.7), 3.83 (3H, s), 4.68 (1H, dd, J 13.1, 6.7), 5.16 (1H, dq, J 9.8,
7.2), 6.20 (1H, br d, J 9.8), 7.0–7.3 (9H, m) δC (CDCl3) 20.5 (q),
22.8 (q), 27.2 (t), 37.3 (d), 52.8 (q), 59.4 (d), 116.1 (d), 129.0–
131.0, 131.8 (s), 137.2 (s), 140.9 (s), 163.2 (s), 167.6 (s), 169.4 (s);
m/z (EI) 365 (Mϩ).
14 (0.15 g, 37%) was a white solid. Mp 79 ЊC from i-Pr2O
(Found: C, 69.04; H, 6.37; N, 11.44; C21H23N3O3 requires C,
69.02; H, 6.34; N, 11.50%); [α]2D5 Ϫ77.2 (CHCl3, c = 0.28); νmax
(Nujol)/cmϪ1 3180, 1720, 1660; δH (CDCl3) 1.30 (3H, d, J 7.2),
2.28 (3H, s), 3.25 (1H, dd, J 18.4, 12.7), 3.59 (1H, dd, J 18.4,
6.5), 3.86 (3H, s), 4.70 (1H, dd, J 12.7, 6.5), 5.16 (1H, dq, J 9.8,
7.2), 6.20 (1H, br d, J 9.8), 7.0–7.3 (9H, m); δC (CDCl3) 20.1 (q),
24.3 (q), 28.8 (t), 39.6 (d), 53.3 (q), 58.5 (d), 116.8 (d), 129.0–
131.0, 131.3 (s), 136.6 (s), 139.9 (s), 162.3 (s), 166.6 (s), 170.1 (s);
m/z (EI) 365 (Mϩ).
MeOPEG-Supported (S )-1-phenylethylamine 9
A solution of (S )-1-phenylethylamine (0.24 g, 2.0 mmol) in dry
toluene (40 cm3) was treated with NaH (90 mg, 3.8 mmol)
and then refluxed for 1 h. MeOPEG-methanesulfonate (5.08 g,
1.0 mmol) in hot (60 ЊC) dry toluene was added and the mixture
was refluxed for 2 h. The solvent was partly removed under
reduced pressure and Et2O (35 cm3) was added. The white
solid was collected by filtration giving pure 9 (4.92 g, 96%)
δH (CDCl3) 1.40 (3H, d, J 6.8, CH3CH ), 1.62 (1H, br s, -CH2-
NH-), 3.34 (3H, s, CH3OCH2-), 3.37 (2H, t, J 7.0, CH3OCH2–-),
3.85 (2H, t, J 7.0, -CH2CH2N ), 4.34 (2H, t, J 7.2, -CH2CH2N ),
5.12–5.22 (1H, m, CH3CH ), 7.30–7.35 (5H, m, aromatics).
MeOPEG-Supported N-[(S )-1-phenylethyl]acrylamide 10
Method A. A solution of N-[(S )-1-phenylethyl]acrylamide12
(0.14 g, 1.2 mmol) in dry toluene (50 cm3) was treated with
NaOH (0.16 g, 4.0 mmol), Na2CO3 (0.13 g, 1.2 mmol) and
tetrabutylammoniun bromide (0.16 g, 0.5 mmol). The mixture
was warmed to 80 ЊC for 0.5 h, and MeOPEG-methane-
sulfonate (5.08 g, 1.0 mmol) in hot (60 ЊC) dry toluene (20 cm3)
was added. After warming (80 ЊC) and stirring for 4 h, the
undissolved material was filtered off, the solvent was partly
removed under reduced pressure and Et2O (25 cm3) was added.
The white solid was collected by filtration giving pure 10
(4.14 g, 80%) δH (CDCl3) 1.40 (3H, d, J 6.8, CH3CH ), 3.34
(3H, s, CH3OCH2-), 3.37 (2H, t, J 7.0, CH3OCH2-), 3.85 (2H, t,
J 7.0, -CH2CH2N ), 4.34 (2H, t, J 7.2, -CH2CH2N ), 5.12–5.22
Homogeneous phase synthesis of cycloadducts 13 and 14
A
solution of N-[(S )-1-phenylethyl]acrylamide (0.88 g,
5.0 mmol) and hydrazonoyl chloride 2 (1.30 g, 5.8 mmol) in
dry toluene was added to triethylamine (2.93 g, 29.0 mmol)
and then refluxed for 6 h. The solvent was evaporated and the
residue was chromatographed on a silica gel column with
AcOEt–hexane–CH2Cl2 3 : 6 : 1. The major isomer 13 (0.66 g,
36%) was eluted first, followed by the minor isomer 14 (0.60 g,
33%). Ratio 13 : 14 = 53 : 47.
(1H, m, CH CH ), 5.60 (1H, dd, J 10.3, 1.6, CH ᎐), 6.08
᎐
2
3
(1H, dd, J 17.5, 10.3, -CH᎐), 6.25 (1H, dd, J 17.5, 1.6, CH ᎐),
᎐
᎐
2
7.30–7.35 (5H, m, aromatics).
(5S)-1-(4-Methylphenyl)-3,5-dicarboxy-4,5-dihydropyrazole and
(5R)-1-(4-methylphenyl)-3,5-dicarboxy-4,5-dihydropyrazole
Method B. A solution of MeOPEG-supported (S )-1-phenyl-
ethylamine 9 (5.10 g, 1.0 mmol) and trioctylamine (0.53 g,
1.5 mmol) in hot (60 ЊC) dry toluene (30 cm3) was added to
acryloyl chloride (0.11 g, 1.2 mmol) and stirred at 80 ЊC for
6 h. The solvent was partly removed under reduced pressure
and Et2O (25 cm3) was added. The white solid was collected by
filtration giving pure 5 (4.85 g, 94%).
A solution of 13 (0.73 g, 2.0 mmol) in tetrahydrofuran (2.5 cm3)
and 2 M NaOH (2.5 cm3) was stirred at 50 ЊC for 4 h. 1 M HCl
was added until the pH 2 reached and AcOEt (50 cm3)
was added. The organic layer was washed with water (20 cm3),
dried over Na2SO4 and evaporated under reduced pressure.
The residue was crystallised from MeOH giving (5S )-1-(4-
methylphenyl)-3,5-dicarboxy-4,5-dihydropyrazole13 (0.34 g,
69%).
MeOPEG-Supported 5-{N-[(S )-1-phenylethyl]amino}carbonyl-
4,5-dihydropyrazoles 11 and 12
The same procedure applied to 14 gave (5R)-1-(4-methyl-
phenyl)-3,5-dicarboxy-4,5-dihydropyrazole13 (0.33 g, 66%).
A
solution of MeOPEG-supported N-[(S )-1-phenylethyl]-
acrylamide 10 (6.21 g, 1.2 mmol), hydrazonoyl chloride 2
(0.36 g, 1.6 mmol) and trioctylamine (1.42 g, 4.0 mmol) in dry
CH2Cl2 (25 cm3) was refluxed with stirring for 50 h. The solvent
was partly removed under reduced pressure and Et2O (25 cm3)
was added. The white solid was collected by filtration giving
a 57 : 43 mixture of cycloadducts 11 and 12 (6.18 g, 96%).
Cycloadduct ratio was deduced from integration of the 1H
NMR resonance signals due to the –COOCH3 group placed
in the 3- position of the 4,5-dihydropyrazole ring: δH (CDCl3)
3.79 (3H, s) (for 11), and 3.82 (3H, s) (for 12).
Acknowledgements
We thank MURST and CNR for financial support.
C.I.N.M.P.I.S. is gratefully acknowledged for a grant that
enabled Dr Pietro Casati to work on this project.
References
1 (a) R. Huisgen, M. Seidel, G. Wallbillich and H. Knupfer,
Tetrahedron, 1962, 17, 3; (b) J. S. Clovis, A. Eckell, R. Huisgen and
R. Sustmann, Chem. Ber., 1967, 100, 60–1593.
2 (a) F. C. Copp, P. J. Islip and J. E. Tateson, Biochem. Pharmacol.,
1984, 33, 339; (b) J. Frígola, A. Colombo, J. Parés, L. Martínez,
R. Sagarra and R. Roser, Eur. J. Med. Chem., 1989, 24, 435.
3 D. J. P. Pinto, M. J. Orwat, S. Wang, J. M. Fevig, M. L. Quan, E.
Amparo, J. Cacciola, K. A. Rossi, R. S. Alexander, A. M.
Smallwood, J. M. Luettgen, L. Liang, B. J. Aungst, M. R. Wright, R.
M. Knabb, P. C. Wong, R. R. Wexler and P. Y. S. Lam, J. Med
Chem., 2001, 44, 566.
1-(4-Methylphenyl)-3-methoxycarbonyl-5-{N-[(S )-1-phenyl-
ethyl]amino}carbonyl-4,5-dihydropyrazoles 13 and 14
A mixture of MeOPEG-supported cycloadducts 11 and 12
(6.18 g, 1.15 mmol) was dissolved in tetrahydrofuran (35 cm3)
and 5% aqueous NaHCO3 (35 cm3) and stirred at room
temperature for 5 h. Et2O (80 cm3) was added, the organic layer
J. Chem. Soc., Perkin Trans. 1, 2002, 2504–2508
2507